WATCHMAN FLX Pro European Registry

Other illness

• Subject has a known hypersensitivity or contraindications according to IFU.

Other

• Subject has a documented life expectancy of less than 12 months.
• Subject who is currently enrolled in another investigational study or registry except when the subject is participating in a mandatory governmental registry, or a purely observational registry with no associated treatments.
• Intracardiac thrombus is present.
• An atrial septal defect repair or closure device or a patent foramen ovale repair or closure device is present.
• The LAA anatomy will not accommodate a Closure Device.
• Subject is of childbearing potential and is, or plans to become, pregnant during the time of the study.

• Subject is attempted to be treated with the WATCHMAN FLX™ Pro LAAC device.
• Subject has non-valvular atrial fibrillation (i.e., atrial fibrillation in the absence of moderate or greater mitral stenosis or a mechanical heart valve) and is clinically indicated for a WATCHMAN FLX™ Pro LAAC device, per the Instructions for Use (IFU).
• Subject or legal representative who are willing and capable of providing informed consent.
• Subject is able and willing to return for required follow-up visits and examinations.
• Subject whose age is 18 years or above, or who is of legal age to give informed consent specific to state and national law.